Results 51 to 60 of about 829,320 (360)

Advances in the management of HPV-related oropharyngeal cancer [PDF]

, 2019
Patients with human papillomavirus- (HPV-) related oropharyngeal squamous cell carcinoma (OPSCC) have a better prognosis than HPV-negative OPSCC when treated with standard high-dose cisplatin-based chemoradiotherapy.
Brugnoletti, O., De Felice, F., de Vincentiis, M., Mezi, S., Polimeni, A., Tombolini, V., Valentini, V.   +6 more
core   +1 more source

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma

Cancer Medicine, 2019
The effect of adjuvant radiotherapy in management for high‐grade meningiomas, especially atypical meningiomas, remains controversial. We aimed to explore the role of adjuvant radiotherapy in this population.
Hongda Zhu, W. Bi, A. Aizer, Lingyang Hua, Mi Tian, J. Den, Hailiang Tang, Hong Chen, Yin Wang, Y. Mao, I. Dunn, Qing Xie, Y. Gong   +12 more
semanticscholar   +1 more source

Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report

Open Life Sciences, 2023
Primary malignant melanoma of the parotid gland (PGMM) is extremely rare, with a poor prognosis. Surgery is the main treatment option followed by adjuvant treatments such as radiotherapy, but which adjuvant treatment to be optimal is still controversial.
Zhao Qiang, Li Zhi-Ke, Gui Yan, Ma Dai-Yuan, Du Guo-Bo, Li Xian-Fu   +5 more
doaj   +1 more source

Hypofractionation in adjuvant breast radiotherapy

The Breast, 2010
Altered fractionation for whole breast irradiation has been extensively studied over the past 20 years, with recent updated publications from several landmark randomized trials. In this review, the radiobiological principles underlying altered fractionation schedules are reviewed, and outcomes, including local control, acute and chronic toxicities from
Bruce G. Haffty, Atif J. Khan
openaire   +3 more sources

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results [PDF]

, 2016
Aim: To report long term oncologic outcomes after adjuvant radiotherapy (RT) for stage I seminoma. Method: We reviewed the complete data set for all patients treated at our institute between 1988 and 2005 for stage I seminoma with adjuvant RT after ...
De Felice, Francesca, Gravina, Giovanni Luca, Marampon, Francesco, Musio, Daniela, Tombolini, Vincenzo   +4 more
core   +2 more sources

Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis

BMC Cancer, 2019
As the efficacy of radiotherapy and chemotherapy for treatment of phyllodes tumors (PTs) remains unclear, this study aimed to review all available data and evaluate the roles of radiotherapy and chemotherapy in PT treatment.
X. Chao, Kai Chen, Jiayi Zeng, Z. Bi, M. Guo, Yi Chen, Yandan Yao, Wei Wu, Shi Liang, Yan Nie   +9 more
semanticscholar   +1 more source

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study

Frontiers in Oncology, 2020
BackgroundIt is well known that neoadjuvant radiotherapy could reduce local recurrence followed by surgical resection. However, evidence about oncologic efficacy of radiotherapy and survival benefit of adjuvant chemotherapy after neoadjuvant radiotherapy
Zhiju Chen, Shaowei Li, Yehong Wang, Zhiming Fu, Ning Liu, Hao Wang, Xin Liu   +6 more
doaj   +1 more source

A Retrospective Analysis using Deep-Learning Models for Prediction of Survival Outcome and Benefit of Adjuvant Chemotherapy in Stage II/III Colorectal Cancer [PDF]

arXiv, 2021
Most early-stage colorectal cancer (CRC) patients can be cured by surgery alone, and only certain high-risk early-stage CRC patients benefit from adjuvant chemotherapies. However, very few validated biomarkers are available to accurately predict survival benefit from postoperative chemotherapy.
arxiv  

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis

MDM Policy & Practice, 2017
Background: Patients undergoing surgery for prostate cancer who have adverse pathological findings experience high rates of recurrence. While there are data supporting adjuvant radiotherapy compared to a wait-and-watch strategy to reduce recurrence rates,
Christopher J. D. Wallis MD, Gerard Morton MD, Angela Jerath MD, Raj Satkunasviam MD, Ewa Szumacher MD, Sender Herschorn MD, Ronald T. Kodama MD, Girish S. Kulkarni MD, David Naimark MD, Robert K. Nam MD   +9 more
doaj   +1 more source

Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?

Frontiers in Oncology, 2017
For pathological high-risk prostate cancer, adjuvant irradiation has shown a survival benefit. Phase III studies have highlighted that half men would face biochemical relapse and would be candidate for radiotherapy at adjuvant or salvage times.
Igor Latorzeff, Paul Sargos, Geneviève Loos, Stéphane Supiot, Stéphane Guerif, Christian Carrie   +5 more
doaj   +1 more source